Australian Regenerative Medicine Institute

The Australian national publicly subsidized: LISTING OF DRUGS FOR PAYMENT BY THE NATIONAL PBS(1)


The PBS is a national, universal, prescription drug insurance scheme, administered by the Commonwealth government. It is the buyer for the country and operates as a monopsony (ie, sole purchaser). It was established in 1953 to provide access to life-saving pharmaceuticals that are affordable, available and of acceptable standards . A benefits schedule, which is a formulary of drugs that are subsidized by the federal government, is published four times a year. buy ortho tri-cyclen online

Drugs may be listed as ‘full benefits’, ‘on authority’ or ‘restricted benefits’, and the list specifies the maximum quantity and the maximum number of repeats if relevant. An unrestricted listing means that the drug is generally available as a benefit, without requirements to be used in a particular manner or for a particular indication. A drug or drug formulation is considered for restricted benefit or authority-required listing “a) to limit PBS usage so that this is in accordance with the approval and registration granted by the TGA; b) to allow the controlled introduction of a drug in a new therapeutic class; c) to limit PBS usage to the indication, conditions or settings seen as being appropriate for clinical, cost-effectiveness, or other reasons; or d) because of concerns about adverse effects, possible misuse, overuse, or abuse.”

Category: Pharmaceutical

Tags: Australian Pharmaceutical Benefits Scheme, Canadian health care, Pharmaceutical policy, Pharmacoeconomics

Leave a Reply

Your email address will not be published. Required fields are marked *